Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXF9DV
|
||||
Drug Name |
2,2,4-Trimethyl-5-[1-phenyl-meth-(Z)-ylidene]-1,2,4,5-tetrahydro-6-oxa-1-aza-chrysen-3-one
|
||||
Synonyms |
CHEMBL32603
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C26H23NO2
|
||||
Canonical SMILES |
CC1C(=O)C(C)(C)Nc2ccc3c4ccccc4O\\C(=C/c5ccccc5)\\c3c12
|
||||
InChI |
InChI=1S/C26H23NO2/c1-16-23-20(27-26(2,3)25(16)28)14-13-19-18-11-7-8-12-21(18)29-22(24(19)23)15-17-9-5-4-6-10-17/h4-16,27H,1-3H3/b22-15-
|
||||
InChIKey |
OCLPHOSZZDWUFZ-JCMHNJIXSA-N
|
||||
Target and Pathway | |||||
Target(s) | Progesterone receptor | Target Info | [1587926] | ||
mRNA of androgen receptor | Target Info | [1587926] | |||
Pathway Interaction Database | Cellular roles of Anthrax toxinsmad2_3nuclearpathway:Regulation of nuclear SMAD2/3 signaling | ||||
Coregulation of Androgen receptor activity | |||||
Regulation of Androgen receptor activity | |||||
Nongenotropic Androgen signaling | |||||
Regulation of nuclear beta catenin signaling and target gene transcription | |||||
FOXA1 transcription factor network | |||||
Notch-mediated HES/HEY network | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.